Paysign Announces Leadership Appointments to Drive Patient Affordability Business Line
Summary
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ:PAYS), a vertically integrated provider of innovative prepaid card programs, digital banking, and processing services for corporate, consumer, and government applications, today announced three leadership appointments. A proven industry veteran, Williams brings a wealth of experience to Paysign, having held a variety of roles at TrialCard, Inc. over a 15-year period, most recently as VP of Business Development, Patient Reimbursement and Engagement Strategy. With new opportunities opening in the space, Paysign has expanded beyond our long-standing pharmaceutical payment offerings and established a Patient Affordability business-line to include other services required by our HUB clients. Such factors include, among others, the inability to continue our current growth rate in future periods; identified material weaknesses in our internal control over financial reporting which could, if not remediated, adversely affect our ability to report our financial condition and results of operations in a timely and accurate manner; that a downturn in the economy, including as a result of COVID-19, could reduce our customer base and demand for our products and services, which could have an adverse effect on our business, financial condition, profitability, and cash flows; operating in a highly regulated environment; failure by us or business partners to comply with applicable laws and regulations; changes in the laws, regulations, credit card association rules or other industry standards affecting our business; that a data security breach could expose us to liability and protracted and costly litigation; and other risk factors set forth in our Form 10-K for the year ended December 31, 2019. Except to the extent required by federal securities laws, the company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events, or otherwise.